Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4(+) T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation

Post-transplantation cyclophosphamide (PTCy) reduces the incidence and severity of graft-versus-host disease (GVHD), thereby improving the safety and accessibility of allogeneic hematopoietic cell transplantation (HCT). We have shown that PTCy works by inducing functional impairment and suppression...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadjis, Ashley D., Nunes, Natalia S., Khan, Shanzay M., Fletcher, Rochelle E., Pohl, Alessandra de Paula, Venzon, David J., Eckhaus, Michael A., Kanakry, Christopher G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886236/
https://www.ncbi.nlm.nih.gov/pubmed/35242129
http://dx.doi.org/10.3389/fimmu.2022.796349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886236/
https://www.ncbi.nlm.nih.gov/pubmed/35242129
http://dx.doi.org/10.3389/fimmu.2022.796349

Ejemplares similares